-
Diet and Cancer: Getting the Research Onto Your PlateNew studies each year purport to show associations between certain foods and cancer. Experts say to focus on the big picture.
by Anne Danahy
-
How Common Are Treatment Breakthroughs?A new study adds nuance to the ‘golden age’ of cancer drug approvals.
by Jon Kelvey
-
New Guidelines Recommend Exercise for Most Cancer PatientsPeople in treatment for early-stage cancer should try to get exercise, according to new recommendations.
by Sandra Gordon
-
E-Cigarettes Don’t Live Up to PromisesNew studies find that electronic cigarettes trail other methods in helping people quit smoking, but they are growing in popularity among teens.
by Teresa Bergen
-
Forward Look
What’s NextNanoscopic biological computer kills cancer cells, spares healthy ones.
by Natalie Slivinksi
-
Forward Look
Drug Combinations for Advanced MelanomaResearchers find that when treating metastatic melanoma, timing is everything.
by Erin O'Donnell
-
Comorbidity: Treating the Whole PatientPatients with cancer often have at least one other chronic disease. Researchers hope to shine a light on how conditions and treatments interact in patients with chronic lymphocytic leukemia and other cancer types.
by Eric Fitzsimmons
-
From the Editor-in-Chief
RAS as an ‘Undruggable’ Drug TargetNew therapies are being developed to attack a previously untreatable cancer mutation.
by William G. Nelson, MD, PhD
-
Disparities in Cervical CancerMany women are being diagnosed with cervical cancer, despite the availability of tools to prevent and diagnose the disease. Black and Hispanic women and low-income and rural populations are especially vulnerable.
by Natalie Slivinski
-
A Look at Disparities Across Cancer CareA new AACR report tracks progress in addressing cancer health disparities and identifies work that still needs to be done.
by Eric Fitzsimmons
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
